Moderna and other vaccine stocks tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed ...

Vaccine experts said the memo was irresponsible and omits key details about how officials arrived at the conclusion.

With much of Moderna’s rise in this decade tied to its COVID-19 vaccine, the company has struggled in recent years to match ...

With no evidence to support the claim that 10 children died due to COVID-19 vaccines, experts unpack the impact of CBER chief ...

At an analyst day event, Moderna said it wants to invest revenue from a hopefully expanded seasonal vaccine franchise into oncology and rare disease programs, to “set the stage for additional growth ...

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...

Moderna is currently in the middle of an aggressive cost-cutting campaign. In September last year, the company announced that ...

Moderna Inc. fell in premarket trading Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market.

Shares of Moderna and BioNTech fell on Monday, likely in response to a FDA official’s memo outlining a link between COVID-19 ...